(2021C) Immunotherapy: Expanding the Scope of Targetable Tumors - Hematology/Oncology

Recorded On: 10/30/2021

  • Register
    • Non-member - $40
    • Member - $30
    • Resident/Fellow - $10
    • Student - $10

Completion of this activity will allow learners to identify the key role of the immune system in cancer surveillance; define the most delineated immune checkpoints - CTLA4 and PDl/PDL axis; and recognize the common common side effects of immunotherapy in cancer.  This program was originally recorded on October 30, 2021 at the ACOI's 2021 Annual Convention and Scientific Sessions.

Norman Ashraf, MD

Associate Professor of Medicine, Div. of Hematology/Oncology

University of South Florida College of Medicine

Tampa, FL

Key:

Complete
Failed
Available
Locked
Acknowledgement
Agree to terms to continue.
Agree to terms to continue.
Video
Open to view video.
Open to view video.
Post-Test
5 Questions  |  Unlimited attempts  |  80/100 points to pass
5 Questions  |  Unlimited attempts  |  80/100 points to pass
CME Certificate
Up to 0.75 medical credits available  |  Certificate available
Up to 0.75 medical credits available  |  Certificate available